Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Diagnostic Imaging market in this environment.
In terms of revenue, this research report indicated that the global Diagnostic Imaging market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Diagnostic Imaging industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Siemens Healthcare aims at producing XX Diagnostic Imaging in 2020, with XX % production to take place in global market, Cairoscan accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Diagnostic Imaging Market by XYZResearch Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Diagnostic Imaging Market?
Siemens Healthcare
Cairoscan
MRC
GE Healthcare
Koninklijke Philips N.V.
Toshiba Medical Systems
Hitachi
Fujifilm
...
Major Type of Diagnostic Imaging Covered in XYZResearch report:
MRI
Ultrasound
CT
X-Ray
SPECT
Hybrid PET
Mammography
Application Segments Covered in XYZResearch Market
OB/Gyn
Cardiology
Oncology
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Diagnostic Imaging Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 MRI -Product Introduction and Major Manufacturers
1.1.2 Ultrasound -Product Introduction and Major Manufacturers
1.1.3 CT -Product Introduction and Major Manufacturers
1.1.4 X-Ray -Product Introduction and Major Manufacturers
1.1.5 SPECT -Product Introduction and Major Manufacturers
1.1.6 Hybrid PET -Product Introduction and Major Manufacturers
1.1.7 Mammography -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Diagnostic Imaging Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
3.1 China Diagnostic Imaging Market
3.1.1 Top Companies leading Diagnostic Imaging Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Diagnostic Imaging Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Diagnostic Imaging Market
3.2.1 Top Companies leading Diagnostic Imaging Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Diagnostic Imaging Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Diagnostic Imaging Market
3.3.1 Top Companies leading Diagnostic Imaging Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Diagnostic Imaging Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Diagnostic Imaging Market
3.4.1 Top Companies leading Diagnostic Imaging Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Diagnostic Imaging Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Diagnostic Imaging Market
3.5.1 Top Companies leading Diagnostic Imaging Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Diagnostic Imaging Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Diagnostic Imaging Market
3.6.1 Top Companies leading Diagnostic Imaging Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Diagnostic Imaging Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Diagnostic Imaging Market
3.7.1 Top Companies leading Diagnostic Imaging Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Diagnostic Imaging Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
4.1 Diagnostic Imaging Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Diagnostic Imaging Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
5.1 Global Diagnostic Imaging Sales and Growth Rate (2021-2026)
5.2 Global Diagnostic Imaging Sales Value and Growth Rate (2021-2026)
6 Diagnostic Imaging Competitive Analysis
6.1 Siemens Healthcare
6.1.1 Siemens Healthcare Company Profiles
6.1.2 Siemens Healthcare Product Introduction
6.1.3 Siemens Healthcare Diagnostic Imaging Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 Cairoscan
6.2.1 Cairoscan Company Profiles
6.2.2 Cairoscan Product Introduction
6.2.3 Cairoscan Diagnostic Imaging Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 MRC
6.3.1 MRC Company Profiles
6.3.2 MRC Product Introduction
6.3.3 MRC Diagnostic Imaging Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 GE Healthcare
6.4.1 GE Healthcare Company Profiles
6.4.2 GE Healthcare Product Introduction
6.4.3 GE Healthcare Diagnostic Imaging Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 Koninklijke Philips N.V.
6.5.1 Koninklijke Philips N.V. Company Profiles
6.5.2 Koninklijke Philips N.V. Product Introduction
6.5.3 Koninklijke Philips N.V. Diagnostic Imaging Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 Toshiba Medical Systems
6.6.1 Toshiba Medical Systems Company Profiles
6.6.2 Toshiba Medical Systems Product Introduction
6.6.3 Toshiba Medical Systems Diagnostic Imaging Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Hitachi
6.7.1 Hitachi Company Profiles
6.7.2 Hitachi Product Introduction
6.7.3 Hitachi Diagnostic Imaging Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Fujifilm
6.8.1 Fujifilm Company Profiles
6.8.2 Fujifilm Product Introduction
6.8.3 Fujifilm Diagnostic Imaging Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
7 Conclusion
The Translational Imaging Solution Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
The Terahertz Imaging Inspection Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
The Cloud-Based Medical Imaging Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
Market Overview
The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...
Market Overview
The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...
Market Overview
The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...
Market Overview
The Global Nuclear Medicine Market is projected to experience significant growth from 2024 to 2034, driven by technological advancements in diagnostic imaging and the increasing demand for targeted radiopharmaceutical therapies. Valued at USD XX.XX billion in 2024, the m...
The Navigation, Imaging and Positioning Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive ...
The Mobile Diagnostic Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...
The Medical Imaging Equipment Maintenance Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive...